NxStage Medical jumps on Q3 beat-and-raise, reveals pipeline
NxStage Medical (NSDQ:NXTM) shares started up today as investors reacted to beat-and-raise results for the home hemodialysis company’s 3rd-quarter and details about its development pipeline.
Lawrence, Mass.-based NxStage said it narrowed its losses by -47.8% to -$1.7 million, or -3¢ per share, on sales growth of 14.9% to $86.5 million compared with Q3 2014. The consensus outlook on Wall Street was for losses of -8¢ on sales of $82.1 million.
“Based on our performance and confidence around the 4th quarter, we are again raising our total revenue guidance for the year,” founder & CEO Jeffrey Burbank ...
Source: Mass Device - November 3, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Dialysis MassDevice Earnings Roundup Wall Street Beat NxStage Medical Inc. Source Type: news
Debiotech and Fresenius Medical Care Announce Exclusive Partnership for New Home Dialysis Product Development
LAUSANNE, Switzerland and BAD HOMBURG, Germany, November 3, 2015 -- (Healthcare Sales & Marketing Network) -- Debiotech SA, a Swiss medical device developer with expertise in innovative technologies and miniaturized medical equipment and devices, and Fres... DevicesDebiotech, Fresenius Medical Care, dialysis, peritoneal dialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 3, 2015 Category: Pharmaceuticals Source Type: news
FDA OKs Baxter's Automated Home Peritoneal Dialysis System FDA OKs Baxter's Automated Home Peritoneal Dialysis System
The AMIA system features two-way remote connectivity, touchscreen controls, and voice guidance for home delivery of peritoneal dialysis. FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 16, 2015 Category: Consumer Health News Tags: Nephrology News Alert Source Type: news
Baxter wins FDA nod for Amia dialysis device
Baxter (NYSE:BAX) said yesterday that it won 510(k) clearance from the FDA for its Amia automated peritoneal dialysis system, saying it plans to launch the device in the U.S. this year.
The Amia device, which uses Deerfield Park, Ill.-based Baxter’s ShareSource web-based remote connection, is designed for home use by patients with end-stage renal disease. Baxter claimed Amia as the sole U.S.-cleared device with voice guidance, touchscreen controls and ShareSource 2-way connectivity.
“PD is an important treatment option for many patients with kidney disease seeking home-based therapy,” Dr. Jaime Uribarr...
Source: Mass Device - October 14, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Dialysis Food & Drug Administration (FDA) Regulatory/Compliance Baxter International Source Type: news
FDA Clears Baxter's Web-Connected Peritoneal Dialysis System
Renal solutions company Baxter International, Inc. announced recently that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its AMIA automated peritoneal dialysis (APD) system with SHARESOURCE web-based remote connectivity. (Source: Medical Design Online News)
Source: Medical Design Online News - October 14, 2015 Category: Medical Equipment Source Type: news
Baxter Announces U.S. FDA Clearance for AMIA Automated Peritoneal Dialysis System with SHARESOURCE Connectivity Platform
System Includes Two-Way Remote Connectivity, Touchscreen Controls and Voice Guidance for Home Patients
DEERFIELD, Ill.--(Healthcare Sales & Marketing Network)--Baxter International Inc. (BAX) announced today the United States Food and Drug Administratio... Devices, FDABaxter, AMIA APD, peritoneal dialysis, ESRD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 13, 2015 Category: Pharmaceuticals Source Type: news
MassDevice.com +3 | The top 3 medtech stories for August 12, 2015
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Study: Edwards’ Sapien and Medtronic’s CoreValve outcomes are similar
A new study published in the Journal of the American College of Cardiology found that patients treated with Edwards Lifesciences’s and Medtronic’s CoreValve showed similar results after 1 year.
The 24...
Source: Mass Device - August 12, 2015 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 3 Source Type: news
NxStage reveals next-gen hemo, peritoneal dialysis systems
NxStage Medical (NSDQ:NXTM) announced 3 new products in the pipeline for the dialysis-focused device company during a conference call discussing their quarterly earnings last week.
Included in the announcements was a next-generation portable hemodialysis system usable at home or in care centers, a new, simplified peritoneal dialysis machine and a critical care system.
“In short, these innovations are designed to give patients even more flexibility in meeting their clinical and lifestyle needs and take us into valuable new segments of our market. We expect these innovations to expand our reach to $5 billion in market ...
Source: Mass Device - August 12, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Dialysis Research & Development NxStage Medical Inc. Outset Medical Source Type: news
NxStage teases at new pipeline products, announces Q2 earnings
NxStage Medical (NSDQ:NXTM) yesterday celebrated the 10 year anniversary mark for FDA approval of its System One home hemodialysis, announced new pipeline developments and Q2 earnings that beat expectations.
The pipeline announcements from Lawrence, Mass.-based were said to include a next generation hemodialysis system, peritoneal dialysis system and a new critical care system, the company said.
“Over the last decade, NxStage’s model of innovation has yielded transformational technologies, including the System One, our dialysate preparation system, and a rich portfolio of integrated offerings and capabilities...
Source: Mass Device - August 7, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Business/Financial News Dialysis MassDevice Earnings Roundup NxStage Medical Inc. Source Type: news
Brooks Memorial to retain dialysis program, for now
Brooks Memorial Hospital is backtracking on a plan to sell the dialysis center within its Dunkirk hospital.
The hospital this week withdrew a certificate-of-need application to sell the 14-station center to University Dialysis Center, a subsidiary of Dialysis Clinic Inc. (DCI), the nation’s largest non-profit dialysis provider.
The initial plan, filed last fall, called for University Dialysis to take over chronic renal dialysis and to add home peritoneal dialysis training and support.
At the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2015 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news
Baxter wins CE Mark for home dialysis device
Baxter International wins CE Mark approval in the European Union for its HomeChoice Claria device for home peritoneal dialysis treatments.
Baxter InternationalNews Well, CE Mark, Dialysis, Regulatory/Compliance, Renalread more (Source: Mass Device)
Source: Mass Device - April 2, 2015 Category: Medical Equipment Authors: Brad Perriello Source Type: news
Peritoneal Dialysis OK for Lupus Patients
(MedPage Today) -- Mortality no worse than in non-lupus ESRD. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 13, 2015 Category: Primary Care Source Type: news
Peritoneal Dialysis Outcomes After Temporary HemodialysisPeritoneal Dialysis Outcomes After Temporary Hemodialysis
Is peritoneal dialysis safe and effective after temporary hemodialysis for peritonitis? Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 14, 2014 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
NxStage study highlights advantages of home hemodialysis
Home hemodialysis device maker NxStage Medical touts a new study showing that kidney patients who underwent frequent home hemodialysis had a better quality of life and lower risk of death than those who underwent peritoneal dialysis.
NxStage Medical Inc.News Well, Clinical Trials, Dialysis, Renalread more (Source: Mass Device)
Source: Mass Device - November 13, 2014 Category: Medical Equipment Authors: Val Kennedy Source Type: news
Dialysis Mode Has Little Influence in Diabetics With ESKDDialysis Mode Has Little Influence in Diabetics With ESKD
The choice of hemodialysis or peritoneal dialysis as a first treatment for diabetics with end-stage kidney disease (ESKD) does not appear to have a definitive influence on outcome, according to a systematic review. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2014 Category: Consumer Health News Tags: Nephrology News Source Type: news
